Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Glass

Showing results (61-70 of 178) with videos related to

Pageof 18
Sort By:
Nature Communications|August 2, 2025
Sporadic ALS induced pluripotent stem cell derived neurons reveal hallmarks of TDP-43 loss of functionJeffrey D Rothstein, Olivia Keeley, Caroline Warlick, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2012
Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALSTerrell E Brotherton, Yingjie Li, Deborah Cooper, et al.
Neurology. Genetics|August 13, 2021
Amyotrophic Lateral Sclerosis Genetic Access Program: Paving the Way for Genetic Characterization of ALS in the ClinicJennifer Roggenbuck, Kelly A Rich, Leah Vicini, et al.
Journal of Medicinal Chemistry|August 10, 2010
Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitorsAsli Ovat, Zhao Zhao Li, Christina Y Hampton, et al.
Stem Cells (Dayton, Ohio)|March 15, 2012
Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patientsJonathan D Glass, Nicholas M Boulis, Karl Johe, et al.
Neurology|August 5, 2016
Comparative analysis of C9orf72 and sporadic disease in an ALS clinic populationMfon E Umoh, Christina Fournier, Yingjie Li, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 23, 2017
Comprehensive analysis to explain reduced or increased SOD1 enzymatic activity in ALS patients and their relativesIsil Keskin, Anna Birve, Mariusz Berdynski, et al.
International Journal of Cancer|July 24, 2009
Non-toxic melanoma therapy by a novel tubulin-binding agentRitu Aneja, Seneshaw Asress, Neerupma Dhiman, et al.
Journal of Neurovirology|February 23, 2013
The spatial relationship between neurons and astrocytes in HIV-associated dementiaEleanor S Roberts, Gursharan Chana, Timothy B Nguyen, et al.
Acta Neuropathologica|October 6, 2016
Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALSJacob I Ayers, Jeffrey Diamond, Adriana Sari, et al.
Pageof 18

Showing results (61-70 of 178) with videos related to

Sort By:
Pageof 18
Nature Communications|August 2, 2025
Sporadic ALS induced pluripotent stem cell derived neurons reveal hallmarks of TDP-43 loss of functionJeffrey D Rothstein, Olivia Keeley, Caroline Warlick, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2012
Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALSTerrell E Brotherton, Yingjie Li, Deborah Cooper, et al.
Neurology. Genetics|August 13, 2021
Amyotrophic Lateral Sclerosis Genetic Access Program: Paving the Way for Genetic Characterization of ALS in the ClinicJennifer Roggenbuck, Kelly A Rich, Leah Vicini, et al.
Journal of Medicinal Chemistry|August 10, 2010
Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitorsAsli Ovat, Zhao Zhao Li, Christina Y Hampton, et al.
Stem Cells (Dayton, Ohio)|March 15, 2012
Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patientsJonathan D Glass, Nicholas M Boulis, Karl Johe, et al.
Neurology|August 5, 2016
Comparative analysis of C9orf72 and sporadic disease in an ALS clinic populationMfon E Umoh, Christina Fournier, Yingjie Li, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 23, 2017
Comprehensive analysis to explain reduced or increased SOD1 enzymatic activity in ALS patients and their relativesIsil Keskin, Anna Birve, Mariusz Berdynski, et al.
International Journal of Cancer|July 24, 2009
Non-toxic melanoma therapy by a novel tubulin-binding agentRitu Aneja, Seneshaw Asress, Neerupma Dhiman, et al.
Journal of Neurovirology|February 23, 2013
The spatial relationship between neurons and astrocytes in HIV-associated dementiaEleanor S Roberts, Gursharan Chana, Timothy B Nguyen, et al.
Acta Neuropathologica|October 6, 2016
Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALSJacob I Ayers, Jeffrey Diamond, Adriana Sari, et al.
Pageof 18